Seelos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-37.88	-73.53	-66.05	-19.1	-51.26	-3.48	0.32	-7.43	-19.02	-21.79	Upgrade
Depreciation & Amortization	0.06	0.05	0	0	0	0	0.12	0.11	0.3	0.17	Upgrade
Share-Based Compensation	3.99	5.07	8.35	2.04	0.46	0.03	1.14	1.75	1.21	1.73	Upgrade
Other Operating Activities	9.93	6.8	8.71	-3.86	31.49	1.86	-12.04	-7.49	-5.13	1.87	Upgrade
Operating Cash Flow	-23.91	-61.6	-49	-20.91	-19.31	-1.58	-10.47	-13.07	-22.64	-18.02	Upgrade
Capital Expenditures	0	0	0	0	0	0	0	-0.02	-0.33	-0.58	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	0	0.05	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	0.28	0.01	0.68	Upgrade
Investing Cash Flow	0	0	0	0	0	0	0	0.27	-0.32	0.15	Upgrade
Share Issuance / Repurchase	19.02	0.56	105.42	15.26	29.52	0	9.63	14.12	10.95	5.87	Upgrade
Debt Issued / Paid	-7.64	-1.89	6.65	11.05	0	1.37	-7.13	-3.12	4.5	1.95	Upgrade
Other Financing Activities	-	-0.27	-	-	-	-	-	-	-	0.04	Upgrade
Financing Cash Flow	11.38	-1.6	112.07	26.31	29.52	1.37	2.5	11	15.45	7.87	Upgrade
Net Cash Flow	-12.54	-63.2	63.07	5.4	10.22	-0.22	4.24	-1.8	-7.51	-10.01	Upgrade
Free Cash Flow	-23.91	-61.6	-49	-20.91	-19.31	-1.58	-10.47	-13.08	-22.97	-18.6	Upgrade
Free Cash Flow Margin	-1085.43%	-	-	-	-5148.00%	-	-	-	-474.77%	-200.83%	Upgrade
Free Cash Flow Per Share	-4.88	-17.37	-16.17	-14.02	-28.52	-15.39	-792.88	-1806.80	-4157.90	-4232.51	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).